Published in J Psychosom Res on May 01, 2006
Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil. AIDS Behav (2008) 1.26
Traumatic stress in acute leukemia. Psychooncology (2011) 1.04
The Cancer Communication Assessment Tool for Patients and Families (CCAT-PF): a new measure. Psychooncology (2008) 0.98
Fatigue after treatment in breast cancer survivors: prevalence, determinants and impact on health-related quality of life. Support Care Cancer (2011) 0.97
An exploratory model of the relationships between cancer-related trauma outcomes on quality of life in non-Hodgkin lymphoma survivors. J Psychosoc Oncol (2011) 0.84
The impact of educating parents of leukemic children on the patients' quality of life. Iran Red Crescent Med J (2011) 0.82
Patient Activation through Counseling and Exercise--Acute Leukemia (PACE-AL)--a randomized controlled trial. BMC Cancer (2013) 0.81
Factors affecting quality of life and fatigue in patients with leukemia under chemotherapy. J Educ Health Promot (2014) 0.80
Prevalence and associates of psychological distress in haematological cancer survivors. Support Care Cancer (2016) 0.80
Physiologic and psychological symptoms experienced by adults with acute leukemia: an integrative literature review. Oncol Nurs Forum (2014) 0.78
Haematological cancer and quality of life: a systematic literature review. Blood Cancer J (2015) 0.77
Quality of life amongst lymphoma survivors in a developing country. Support Care Cancer (2016) 0.77
Prevalence and Positive Correlates of Posttraumatic Stress Disorder Symptoms among Chinese Patients with Hematological Malignancies: A Cross-Sectional Study. PLoS One (2015) 0.76
The Socio-Demographic and Clinical Factors Associated with Quality of Life among Patients with Haematological Cancer in a Large Government Hospital in Malaysia. Malays J Med Sci (2011) 0.76
Gentle Massage Improves Disease- and Treatment-Related Symptoms in Patients with Acute Myelogenous Leukemia. J Clin Trials (2014) 0.75
Depression and anxiety in patients with hematological malignancies, prevalence, and associated factors. Saudi Med J (2016) 0.75
The influence of unmet supportive care needs on anxiety and depression during cancer treatment and beyond: a longitudinal study of survivors of haematological cancers. Support Care Cancer (2017) 0.75
A prospective study of changes in anxiety, depression, and problems in living during chemotherapy treatments: effects of age and gender. Support Care Cancer (2017) 0.75
The Dyadic Effects of Family Cohesion and Communication on Health-Related Quality of Life: The Moderating Role of Sex. Cancer Nurs (2017) 0.75
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. Blood (2008) 2.00
Is the follicular lymphoma international prognostic index better than the international prognostic index to identify high-risk follicular lymphoma patients? Leuk Lymphoma (2007) 1.48
Prognostic impact of cancer/testis antigen expression in advanced stage multiple myeloma patients. Cancer Immun (2008) 1.45
Can thalidomide be effective to treat plasma cell leptomeningeal infiltration? Eur J Haematol (2003) 1.41
Confirmation of the utility of the International Staging System and identification of a unique pattern of disease in Brazilian patients with multiple myeloma. Haematologica (2008) 1.07
Primary breast lymphoma: an uncommon but curable disease. Leuk Lymphoma (2003) 0.96
Detection and possible prognostic relevance of p53 gene mutations in diffuse large B-cell lymphoma. An analysis of 51 cases and review of the literature. Leuk Lymphoma (2004) 0.89
The role of regulatory T cells and TH17 cells in multiple myeloma. Clin Dev Immunol (2012) 0.89
Is mindfulness associated with insomnia after menopause? Menopause (2014) 0.88
Isochromosome 17q in MDS: a marker of a distinct entity. Cancer Genet Cytogenet (2006) 0.87
SAGE analysis highlights the importance of p53csv, ddx5, mapkapk2 and ranbp2 to multiple myeloma tumorigenesis. Cancer Lett (2009) 0.87
TGFbetaR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma. Int J Cancer (2009) 0.87
Altered immunophenotypic features of peripheral blood platelets in myelodysplastic syndromes. Haematologica (2012) 0.86
MAGE-C1/CT7 and MAGE-C2/CT10 are frequently expressed in multiple myeloma and can be explored in combined immunotherapy for this malignancy. Cancer Immunol Immunother (2012) 0.86
Frequency and prognostic relevance of cancer testis antigen 45 expression in multiple myeloma. Exp Hematol (2009) 0.85
Formulas used by Tibetan doctors at Men-Tsee-Khang in India for the treatment of neuropsychiatric disorders and their correlation with pharmacological data. Phytother Res (2012) 0.84
Cancer/Testis Antigen MAGE-C1/CT7: new target for multiple myeloma therapy. Clin Dev Immunol (2012) 0.83
Chronic myeloid leukemia in an XX male. Cancer Genet Cytogenet (2007) 0.83
Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines. PLoS One (2011) 0.83
FLT3 internal tandem duplication during myelodysplastic syndrome follow-up: a marker of transformation to acute myeloid leukemia. Cancer Genet Cytogenet (2008) 0.82
Single-nucleotide polymorphism-array improves detection rate of genomic alterations in core-binding factor leukemia. Med Oncol (2013) 0.82
Bilateral central retinal vein occlusion associated with multiple myeloma. Ophthalmologica (2004) 0.81
The 5q- syndrome and autoimmune phenomena: report of three cases. Leuk Res (2005) 0.80
Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myeloma. Eur J Haematol (2004) 0.80
Evaluation of LAGE-1 and NY-ESO-1 expression in multiple myeloma patients to explore possible benefits of their homology for immunotherapy. Cancer Immun (2011) 0.80
Epstein-Barr viral load, interleukin-6 and interleukin-10 levels in post-transplant lymphoproliferative disease: a nested case-control study in a renal transplant cohort. Leuk Lymphoma (2005) 0.79
Comparative expression of a set of genes to an internal housekeeping control in CDNA amplified and not amplified by PolyAPCR in non-Hodgkin's lymphoma samples obtained from fine-needle aspiration cytology. Diagn Mol Pathol (2010) 0.79
Combined flow cytometric assessment of CD45, HLA-DR, CD34, and CD117 expression is a useful approach for reliable quantification of blast cells in myelodysplastic syndromes. Cytometry B Clin Cytom (2013) 0.79
p16 gene methylation lacks correlation with angiogenesis and prognosis in multiple myeloma. Cancer Lett (2004) 0.78
Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin's lymphoma patients. Cancer Immunol Immunother (2012) 0.78
Chronic myeloid leukemia following kidney transplantation. Leuk Res (2005) 0.77
Adding FISH to karyotype in Myelodysplastic syndrome investigation diagnosis: are all questions answered? Leuk Res (2009) 0.77
Brain imaging analysis can identify participants under regular mental training. PLoS One (2012) 0.77
Proangiogenic cytokines produced by non-Hodgkin lymphoma tumor cells induce angiogenesis in infiltrated bone marrow samples. Leuk Lymphoma (2009) 0.77
Impact of highly active antiretroviral therapy in the treatment of HIV-infected patients with systemic non-Hodgkin's lymphoma. Acta Oncol (2002) 0.77
Advances in the treatment of multiple myeloma: the role of thalidomide. Leuk Lymphoma (2003) 0.77
Expression of eight genes of nuclear factor-kappa B pathway in multiple myeloma using bone marrow aspirates obtained at diagnosis. Histol Histopathol (2009) 0.76
Understanding myeloma cancer stem cells. Immunotherapy (2013) 0.76
Autologous stem cell transplantation improves quality of life in economically challenged, Brazilian multiple myeloma patients. Clinics (Sao Paulo) (2011) 0.76
Number of expressed cancer/testis antigens identifies focal adhesion pathway genes as possible targets for multiple myeloma therapy. Leuk Lymphoma (2010) 0.75
Association of myelodysplastic syndrome with CD5+, CD23+ monoclonal B-cell lymphocytosis. Clinics (Sao Paulo) (2012) 0.75
Serum free light chains and post-transplant lymphoproliferative disorder in patients with renal transplant. Leuk Lymphoma (2013) 0.75
Trisomies 14 and 22 in acute myelocytic leukemia with multilineage dysplasia. Cancer Genet Cytogenet (2004) 0.75
Activation of the Janus kinase/signal transducer and activator of transcription pathway in multiple myeloma is not related to point mutations in kinase and pseudokinase domains of JAK1. Leuk Lymphoma (2013) 0.75
Quantification of Epstein-Barr viral load and determination of a cut-off value to predict the risk of post-transplant lymphoproliferative disease in a renal transplant cohort. Haematologica (2004) 0.75
A rare case of acute myeloid leukemia evolving from a myelodysplastic syndrome with der(19)t(1;19). Cancer Genet Cytogenet (2006) 0.75
Reciprocal Cdc25A and p27 expression in B-cell non-Hodgkin lymphomas. Diagn Mol Pathol (2003) 0.75
Aggressive systemic mastocytosis: is there a role for trisomy 8? Leuk Res (2004) 0.75
FLT3 mutation and AML/ETO in a case of Myelodysplastic syndrome in transformation corroborates the two hit model of leukemogenesis. Leuk Res (2006) 0.75
Amphotericin B-induced severe hypertension in a young patient: case report and review of the literature. Ren Fail (2006) 0.75
Iron staining in gammopathy-related crystal-storing histiocytosis: a misleading feature to the differential diagnosis with Gaucher's disease. Mol Genet Metab (2013) 0.75